Literature DB >> 1431125

Primary structure of cobra complement component C3.

D C Fritzinger1, E C Petrella, M B Connelly, R Bredehorst, C W Vogel.   

Abstract

Complement component C3 is a multifunctional protein known to interact specifically with more than 10 different plasma proteins or cell surface receptors. Cobra venom contains cobra venom factor, a structural analogue of C3 that shares some properties with C3 (e.g., formation of a C3/C5 convertase) but differs in others (e.g., susceptibility to regulation by factors H and I). The elucidation of structural differences between C3 and cobra venom factor can be expected to help identify functionally important regions of C3 molecules. To that end we have undertaken the molecular cloning of both cobra C3 and cobra venom factor to take advantage of the unique biologic system where both proteins are produced by the same species. We report the primary structure of cobra C3 mRNA and the derived protein structure. Cobra C3 mRNA is 5211 bp in length. It contains an open reading frame of 4953 bp coding for a single pre-pro-C3 molecule, consisting of a 22-amino acid signal sequence, a 633-amino acid beta-chain (70 kDa), and a 992-amino acid alpha-chain (112 kDa) which is separated from the beta-chain by four arginine residues. There are no N-glycosylation sites in cobra C3. Cobra C3 exhibits approximately 58% nucleotide sequence identity with C3 from mammalian species. At the protein level, sequence identity is approximately 52% and sequence similarity approximately 71%. All 27 cysteine residues are highly conserved as are the C3 convertase cleavage site, the thioester site, and the factor B binding site. Cobra C3 also seems to have homologous binding sites for factor H and properdin, as well as a conserved sequence in the functionally important region of the C3a anaphylatoxin. The sequence homology at the CR2 and CR3 binding sites does not exceed the overall sequence homology. Accordingly, the existence of CR2 and CR3 binding sites can neither be deduced nor excluded.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431125

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Allergen nomenclature. IUIS/WHO Allergen Nomenclature Subcommittee.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

2.  Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.

Authors:  I Murray; J Köhl; K Cianflone
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

3.  Molecular cloning and derived primary structure of cobra venom factor.

Authors:  D C Fritzinger; R Bredehorst; C W Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase.

Authors:  Chieko Yamamoto; Daisuke Tsuru; Naoko Oda-Ueda; Motonori Ohno; Shosaku Hattori; Sung-Teh Kim
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Fourth component of Xenopus laevis complement: cDNA cloning and linkage analysis of the frog MHC.

Authors:  R Mo; Y Kato; M Nonaka; K Nakayama; M Takahashi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 6.  Genomic view of the evolution of the complement system.

Authors:  Masaru Nonaka; Ayuko Kimura
Journal:  Immunogenetics       Date:  2006-08-09       Impact factor: 2.846

7.  Restriction and recruitment-gene duplication and the origin and evolution of snake venom toxins.

Authors:  Adam D Hargreaves; Martin T Swain; Matthew J Hegarty; Darren W Logan; John F Mulley
Journal:  Genome Biol Evol       Date:  2014-08       Impact factor: 3.416

8.  The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins.

Authors:  Kushal Suryamohan; Sajesh P Krishnankutty; Joseph Guillory; Matthew Jevit; Markus S Schröder; Meng Wu; Boney Kuriakose; Oommen K Mathew; Rajadurai C Perumal; Ivan Koludarov; Leonard D Goldstein; Kate Senger; Mandumpala Davis Dixon; Dinesh Velayutham; Derek Vargas; Subhra Chaudhuri; Megha Muraleedharan; Ridhi Goel; Ying-Jiun J Chen; Aakrosh Ratan; Peter Liu; Brendan Faherty; Guillermo de la Rosa; Hiroki Shibata; Miriam Baca; Meredith Sagolla; James Ziai; Gus A Wright; Domagoj Vucic; Sangeetha Mohan; Aju Antony; Jeremy Stinson; Donald S Kirkpatrick; Rami N Hannoush; Steffen Durinck; Zora Modrusan; Eric W Stawiski; Kristen Wiley; Terje Raudsepp; R Manjunatha Kini; Arun Zachariah; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2020-01-06       Impact factor: 38.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.